In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Kiwi company turns kiwi waste into leather
In New Zealand, a startup called KiwiLeather Innovations is building a business converting rejected kiwifruit into a leather alternative.
According to Fresh Plaza, over...
UPSIDE Foods serves cultivated chicken at Indy 500 ahead of state ban
In Indiana, UPSIDE Foods served cultivated chicken sandwiches during the recent Indianapolis 500 as it called the state’s upcoming ban on such products “un-American.”...
Bee-free honey maker MeliBio acquired by FoodYoung Labs
In California, MeliBio, a pioneer in bee-free food, has been acquired by Switzerland-based foodtech FoodYoung Labs for an undisclosed sum.
MeliBio has earned global...